Dong-E-E-Jiao Co., Ltd. is a high-risk Chinese pharmaceutical company specializing in the manufacturing and sale of Chinese herbs, traditional medicines, and healthcare products. With a Risk Rating Score of 36.0, Dong-E-E-Jiao exports its products globally, including to Europe, the United States, and Southeast Asia. Known for its focus on ESG principles, the company is committed to environmental sustainability and governance practices.